Skip to main content
Fig. 1 | Trials

Fig. 1

From: Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial

Fig. 1

Study design. Arrows indicate the application time points of secukinumab and placebo; stars indicate the time points at which imaging (ultrasound and/or magnetic resonance angiography) is performed. BSL, baseline; mg, milligram; s.c., subcutaneous; R, randomization (randomization occurs after the 6-week screening period at baseline); n, number

Back to article page

Trials

ISSN: 1745-6215